Literature DB >> 24771624

B cells in multiple sclerosis: good or bad guys?: An article for 28 May 2014 - World MS Day 2014.

Franziska Hoffmann1, Edgar Meinl.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24771624     DOI： 10.1002/eji.201470045

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


× No keyword cloud information.
  9 in total

1.  MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.

Authors:  Marta Wagner; Maciej Sobczyński; Małgorzata Bilińska; Anna Pokryszko-Dragan; Małgorzata Cyrul; Piotr Kuśnierczyk; Monika Jasek
Journal:  J Mol Neurosci       Date:  2015-01-20       Impact factor: 3.444

2.  Single dose of glycoengineered anti-CD19 antibody (MEDI551) disrupts experimental autoimmune encephalomyelitis by inhibiting pathogenic adaptive immune responses in the bone marrow and spinal cord while preserving peripheral regulatory mechanisms.

Authors:  Ding Chen; Monica Blazek; Sara Ireland; Sterling Ortega; Xiangmei Kong; Anouk Meeuwissen; Ann Stowe; Laura Carter; Yue Wang; Ronald Herbst; Nancy L Monson
Journal:  J Immunol       Date:  2014-10-03       Impact factor: 5.422

3.  Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis.

Authors:  Elisa Mazzoni; Silvia Pietrobon; Irene Masini; John Charles Rotondo; Mauro Gentile; Enrico Fainardi; Ilaria Casetta; Massimiliano Castellazzi; Enrico Granieri; Maria Luisa Caniati; Maria Rosaria Tola; Giovanni Guerra; Fernanda Martini; Mauro Tognon
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 4.  Primary Progressive Multiple Sclerosis: Putting Together the Puzzle.

Authors:  Ahmed Abdelhak; Martin S Weber; Hayrettin Tumani
Journal:  Front Neurol       Date:  2017-05-31       Impact factor: 4.003

5.  Preliminary Study on the Role of TMEM39A Gene in Multiple Sclerosis.

Authors:  Marta Wagner; Maciej Sobczyński; Małgorzata Bilińska; Anna Pokryszko-Dragan; Małgorzata Cyrul; Piotr Kuśnierczyk; Monika Jasek
Journal:  J Mol Neurosci       Date:  2017-04-25       Impact factor: 3.444

6.  Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.

Authors:  Maria Hjorth; Nicolae Dandu; Johan Mellergård
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

Review 7.  Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology.

Authors:  Fabian Szepanowski; Clemens Warnke; Gerd Meyer Zu Hörste; Anne K Mausberg; Hans-Peter Hartung; Christoph Kleinschnitz; Mark Stettner
Journal:  CNS Drugs       Date:  2021-10-16       Impact factor: 5.749

8.  Neurological Disease-Affected Patients, including Multiple Sclerosis, Are Poor Responders to BKPyV, a Human Polyomavirus.

Authors:  Ilaria Bononi; Elisa Mazzoni; Silvia Pietrobon; Maria Rosa Iaquinta; Andrea Caselli; Elena Torreggiani; Maura Pugliatti; Ilaria Casetta; Massimiliano Castellazzi; Enrico Granieri; Fernanda Martini; Mauro Tognon
Journal:  J Immunol Res       Date:  2022-07-26       Impact factor: 4.493

9.  The influence of retinoic acid on the human oligodendrocyte precursor cells by RNA-sequencing.

Authors:  Sun Young Kim; Eve E Kelland; Ji Hong Kim; Brett T Lund; Xiao Chang; Kai Wang; Leslie P Weiner
Journal:  Biochem Biophys Rep       Date:  2016-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.